SCHEMBL1940764

SCHEMBL1940764

Cc1c(N)cccc1C(=O)c1cn(C(C)C)c2ncnc(N)c12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 1/20 0.54
PDPK1 O15530 6/20 0.53
LCK P06239 6/20 0.51
RET P07949 4/20 0.51
SRC P12931 3/20 0.51
PIK3CD O00329 1/20 0.49
PIK3CA P42336 1/20 0.49
PIK3CB P42338 1/20 0.49
PIK3CG P48736 1/20 0.49
PRKDC P78527 1/20 0.49
KDR P35968 4/20 0.48
TEK Q02763 4/20 0.48
NTRK1 P04629 5/20 0.46
NTRK2 Q16620 3/20 0.46
KCNH2 Q12809 3/20 0.46
NTRK3 Q16288 2/20 0.46
AKT1 P31749 2/20 0.44
MTOR P42345 2/20 0.44
AURKA O14965 1/20 0.43
GSK3B P49841 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1940942 0.88 PDGFRB (0.58) PDGFRBPDPK1LCKRETSRC
SCHEMBL1940620 0.84 PDGFRB (0.54) PDGFRBPDPK1LCKRETSRC
SCHEMBL6223045 0.82 PDGFRB (0.57) PDGFRBPDPK1LCKRETSRC
SCHEMBL1940057 0.81 PDGFRB (0.59) PDGFRBPDPK1LCKRETSRC
SCHEMBL5353143 0.81 PDGFRB (0.49) PDGFRBPDPK1LCKRETSRC
SCHEMBL1942062 0.80 PDGFRB (0.67) PDGFRBPDPK1LCKRETSRC
SCHEMBL4090394 0.80 PDPK1 (0.61) PDGFRBPDPK1LCKRETSRC
SCHEMBL1941731 0.79 NTRK1 (0.49) PDGFRBPDPK1LCKRETSRC
SCHEMBL1942117 0.79 PDGFRB (0.65) PDGFRBPDPK1LCKRETSRC
SCHEMBL1940451 0.79 PDGFRB (0.50) PDGFRBPDPK1LCKRETSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1578751-B1 PYRROLOPYRIMIDINE DERIVATIVES PFIZER PROD INC (US) 2011-06-15 EP disclosed
US-7271262-B2 Pyrrolopyrimidine derivatives PFIZER INC (US) 2007-09-18 US disclosed
EP-1578751-A1 PYRROLOPYRIMIDINE DERIVATIVES Pfizer Products Inc. (US) 2005-09-28 EP disclosed
US-20050037999-A1 Pyrrolopyrimidine derivatives PFIZER INC 2005-02-17 US disclosed
WO-2004056830-A1 PYRROLOPYRIMIDINE DERIVATIVES PFIZER PRODUCTS INC. (US) 2004-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050037999-A1 Pyrrolopyrimidine derivatives CCNA1, CCNT1, TP53 PDGFRB 2465/4885PDPK1 832/4885LCK 1610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.